Top Mover

Axon Enterprise Stock Tumbles 10% After $1 Billion Zero-Coupon Convertible Notes Offering

Read this in the Market Flux app

Axon Enterprise, Inc. $AXON

$442.08-9.82%as of publication

5D Change
-12.53%
Market Cap
$38.64B

Axon Enterprise fell as much as 10% on September 15, 2026, becoming the worst-performing stock in the S&P 500 that day, after the company announced plans to sell $1 billion in zero-coupon convertible senior notes due 2031. The offering carries no interest cost to Axon but will dilute shareholders if converted into equity, a prospect that rattled investors and erased roughly $4 billion in market capitalization, a figure that dwarfed the $1 billion the company sought to raise.

Axon filed a Form 8-K with regulators on September 15 disclosing the offering details. Options activity in AXON shares was notably elevated as traders repositioned around the news. Adding to the headline pressure, the company's chief legal officer separately sold $488,617 worth of stock on the same day, though insider sales on a scheduled plan are common and were not cited as a direct cause of the decline.

Axon was already on watchlists heading into the session as a large-cap defense technology name to monitor amid broader yield and crude oil volatility. The convertible note selloff overshadowed any other near-term catalysts and left the stock as a clear underperformer relative to its sector peers on the day.

© AI-generated summary is provided by Market Flux

Sources

  1. Wallstengine$AXON LAUNCHES A $1B ZERO-COUPON CONVERTIBLE
  2. Marketsday#US & Global Equities — #Pre-Market & Trending Watchlist — September 15, 2026 🔹 $VERA (Vera Therapeutics) Reports Major Phase 3 Success:$VERA surged in early action after announcing that its lead drug candidate, *trutakna*, successfully met all primary efficacy endpoints in the final analysis of the Phase 3 ORIGIN 3 trial for IgA nephropathy. 🔹 $ETSY Gains on Oppenheimer Upgrade to Outperform:$ETSY saw buying interest after Oppenheimer upgraded the stock from Perform to Outperform with a $90 price target, citing AI-powered search enhancements, product platform updates, and stronger mobile app engagement. 🔹 $RKLB (Rocket Lab) Completes $1.9B Equity Financing: $RKLB traded heavily after completing a $1.9 billion equity offering to fund its strategic acquisition deal with Iridium, while analysts maintain strong upside forecasts based on Electron and Neutron rocket execution. 🔹 $WAY (Way 2 Vat) Applies for New Equity Quotation: Australian-listed $WAY issued 42.18 million ordinary shares at AUD $0.05 under its previously disclosed capital placement structure. 🔹 $LLY, $NOK, $AXON, $PLAY & $ENVA Watchlist Action: Large-cap healthcare leader $LLY, defense tech innovator $AXON, enterprise network giant $NOK, experiential dining group $PLAY, and specialty finance firm $ENVA continue to monitor key technical moving average supports and broad market sentiment amid ongoing yield and crude volatility. #USStocks #PreMarket #VERA #ETSY #RKLB #WallStreet #EquityUpdate #MarketTrends
  3. barrons.comWhy This Taser Maker's Stock Is Today's Worst in the S&P 500
  4. NasdaqWhy Axon Enterprise Stock Was Tumbling Today
  5. MarketAXON announces the intent to sell $1 billion 0% convertible senior notes due 2031, and the stock is down $4 billion. It would be funny if it weren't real downticks. $AXON
  6. MarketWatchAxon Enterprise Inc. stock underperforms Tuesday when compared to competitors
  7. Seeking AlphaAxon Enterprise retreats 10% on proposed $1N note offering